1. UESPI
  2. Poeta Torquato Neto – TERESINA
  3. CCS
  4. CCS - Bacharelado em Medicina (Poeta Torquato Neto – TERESINA)
Exportar este item: EndNote BibTex

Use este identificador para citar ou linkar para este item: https://sistemas2.uespi.br/handle/tede/1785
Registro completo de metadados
Campo DCValorIdioma
dc.creatorCosta, Rafael Everton Assunção Ribeiro da-
dc.creator.Latteshttp://lattes.cnpq.br/8947918346770632por
dc.contributor.advisor1Valença, Rodrigo José de Vasconcelos-
dc.contributor.advisor1Latteshttp://lattes.cnpq.br/7756846284747245por
dc.contributor.advisor-co1Sá, Carlos Eduardo Coelho de-
dc.contributor.advisor-co1Latteshttp://lattes.cnpq.br/7898455907251875por
dc.contributor.referee1Valença, Rodrigo José de Vasconcelos-
dc.contributor.referee1Latteshttp://lattes.cnpq.br/7756846284747245por
dc.contributor.referee2Pinto, Lucielma Salmito Soares-
dc.contributor.referee2Latteshttp://lattes.cnpq.br/6181801128009373por
dc.contributor.referee3Sá, Carlos Eduardo Coelho de-
dc.contributor.referee3Latteshttp://lattes.cnpq.br/7898455907251875por
dc.date.accessioned2025-04-25T17:03:45Z-
dc.date.issued2024-
dc.identifier.citationCOSTA, Rafael Everton Assunção Ribeiro da. Sobrevida e fatores prognósticos em pacientes com câncer de mama : um estudo de coorte. 2024. 59 f. Monografia (Bacharelado em Medicina) - Universidade Estadual do Piauí, Teresina-PI.por
dc.identifier.urihttp://sistemas2.uespi.br/handle/tede/1785-
dc.description.provenanceSubmitted by Rafael Everton Assunção Ribeiro da Costa (rafaelcosta@aluno.uespi.br) on 2025-04-19T17:27:52Z No. of bitstreams: 2 Monografia completa.pdf: 4182908 bytes, checksum: 6dcd2273ced356e7f571a088cb295d01 (MD5) Termo de autorizacao para publicacao.pdf: 671656 bytes, checksum: b7676874b35fa7d34fac17113710465a (MD5)eng
dc.description.provenanceApproved for entry into archive by Francisco Santos (fnorberto@ccs.uespi.br) on 2025-04-25T17:03:45Z (GMT) No. of bitstreams: 2 Monografia completa.pdf: 4182908 bytes, checksum: 6dcd2273ced356e7f571a088cb295d01 (MD5) Termo de autorizacao para publicacao.pdf: 671656 bytes, checksum: b7676874b35fa7d34fac17113710465a (MD5)eng
dc.description.provenanceMade available in DSpace on 2025-04-25T17:03:45Z (GMT). No. of bitstreams: 2 Monografia completa.pdf: 4182908 bytes, checksum: 6dcd2273ced356e7f571a088cb295d01 (MD5) Termo de autorizacao para publicacao.pdf: 671656 bytes, checksum: b7676874b35fa7d34fac17113710465a (MD5) Previous issue date: 2024-01-31eng
dc.formatapplication/pdf*
dc.languageporpor
dc.publisherUniversidade Estadual do Piauípor
dc.publisher.departmentCentro de Ciencias da Saudepor
dc.publisher.countryBrasilpor
dc.publisher.initialsUESPIpor
dc.publisher.programBacharelado em Medicinapor
dc.relation.referencesANATOMIA patológica no câncer de mama. DB Diagnósticos, 2020. Disponível em: https://diagnosticosdobrasil.com.br/artigo/anatomia-patologica-no-cancer-de- mama#:~:text=O%20exame%20anatomopatol%C3%B3gico%20consiste%20na,peq ueno%2C%20m%C3%A9dio%20ou%20grande%20porte. Acesso em: 16 de julho de 2023. AYALA, A. L. M. et al. Sobrevida em 10 anos em mulheres com câncer de mama: coorte história de 2000-2014. Ciência & Saúde Coletiva, Rio de Janeiro, v. 24, n. 4, p. 1537-1550, 2019. BREAST Cancer Stages. American Cancer Society, 2021. Disponível em: https://cancer.org/cancer/types/breast-cancer/understanding-a-breast-cancer- diagnosis/stages-of-breast-cancer.html. Acesso em: 16 de julho de 2023. CANCER Stat Facts: Female Breast Cancer. National Institutes of Health, 2020. Disponível em: https://seer.cancer.gov/statfacts/html/breast.html. Acesso em: 16 de julho de 2023. CARDOSO, F. et al. Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†. Annals of Oncology, Amsterdã, v. 30, n. 8, p. 1194-1220, 2019. CHEN, Z. et al. Trends of female and male breast cancer incidence at the global, regional, and national levels, 1990–2017. Breast Cancer Research and Treatment, Berlim, v. 180, n. 2, p. 481-490, 2020. DIFERENÇAS entre CACON X UNACON. Sociedade Brasileira de Cirurgia Oncológica (SBCO), 2022. Disponível em: https://sbco.org.br/dieferencas-cacom- unacom/. Acesso em: 16 de julho de 2023. DINIZ, R. W. et al. Disease-free survival in patients with non-metastatic breast cancer. Revista da Associação Médica Brasileira (1992), São Paulo, v. 62, n. 5, p. 407-413, 2016. DONEGAN, W. Tumor-Related Prognostic Factors for Breast Cancer. CA: A Cancer Journal for Clinicians, Hoboken, v. 47, n. 1, p. 28-51, 1997. ESTEVA, F. J. et al. Immunotherapy and targeted therapy combinations in metastatic breast cancer. The Lancet Oncology, Amsterdã, v. 20, n. 3, p. e175-e186, 2019. ESTIMATIVA 2023: incidência de câncer no Brasil. Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA), 2022. Disponível em: https://inca.gov.br/publicacoes/livros/estimativa-2023-incidencia-de-cancer-no-brasil. Acesso em: 16 de julho de 2023. ESTRELA, C. Métodos de pesquisa: Metologia Científica. 3. Ed. Porto Alegre: Artes Médicas, 2018. FAKHRI, N. et al. Risk factors for breast cancer in women: an update review. Medical Oncology, Berlim, v. 39, n. 12, p. 197, 2022. FOX, S.; SPEIRS, V.; SHAABAN, A. M. Male breast cancer: an update. Virchows Archiv, Berlim, v. 480, n. 1, p. 85-93, 2022. FUJII, T. et al. Revisiting the definition of estrogen receptor positivity in HER2- negative primary breast cancer. Annals of Oncology, Amsterdã, v. 28, n. 10, p. 2420-2428, 2017. GAO, Y.; SAMREEN, N.; HELLER, S. Non- BRCA Early-Onset Breast Cancer in Young Women. Radiographics, Oak Brook, v. 42, n. 1, p. 5-22, 2022. GODONE, R. L. N. et al. Clinical and molecular aspects of breast cancer: Targets and therapies. Biomedicine & Pharmacotherapy, Amsterdã, v. 106, p.14-34, 2018. GONÇALVES JR., H. Survival Study of Triple-Negative and Non-Triple-Negative Breast Cancer in a Brazilian Cohort. Clinical Medicine Insights: Oncology, Thousand Oaks, v. 12, p. 1179554918790563, 2018. GUCALP, A. et al. Male breast cancer: a disease distinct from female breast cancer. Breast Cancer Research and Treatment, Berlim, v. 173, n. 1, p. 37-48, 2019. HARRELL JR., F. E. Cox Proportional Hazards Regression Model. In: HARRELL JR., F. E. Regression Modeling Strategies. 2. Ed. Nova Iorque: Springer, 2015. P. 475- 519. HASSETT, M. J. et al. Management of Male Breast Cancer: ASCO Guideline. Journal of Clinical Oncology, Warrenton, v. 38, n. 16, p. 1849-1863, 2020. IMUNO-HISTOQUÍMICA no câncer de mama. DB Diagnósticos, 2020. Disponível em: https://diagnosticosdobrasil.com.br/artigo/imuno-histoquimica-no-cancer-de- mama. Acesso em: 16 de julho de 2023. INGALE, Y. P. et al. Invasive Papillary Carcinoma of the Breast – A Rare Case Report. Medical Journal of Dr. DY Patil Vidyapeeth, Alphen aan den Rijn, v. 15, n. 5, p. 782-784, 2022. LEE, Y. T., TAN, Y. J. e OON, C. E. Molecular targeted therapy: Treating cancer with specificity. European Journal of Pharmacology, Amsterdã, v. 834, p. 188-196, 2018. LIBSON, S. e LIPPMAN, M. A review of clinical aspects of breast cancer. International Review of Psychiatry, Londres, v. 26, n. 1, p. 4-15, 2014. MARRAZZO, E. et al. Mucinous breast cancer: A narrative review of the literature and a retrospective tertiary single-centre analysis Author links open overlay panel. The Breast, Amsterdã, v. 49, p. 87-92, 2020. MOMENIMOVAHED, Z. e SALEHINIYA, H. Epidemiological characteristics ofand risk factors for breast cancer in the world. Breast Cancer – Targets and Therapy, Macclesfield, v. 11, p. 151-164, 2019. MUTAI, R. et al. Prognostic impact of HER2-low expression in hormone receptor positive early breast cancer. The Breast, Amsterdã, v. 60, p. 62-69, 2021. PHUNG, M. T., TIN, S. T. e ELWOOD, J. W. Prognostic models for breast cancer: a systematic review. BMC Cancer, Londres, v. 19, n. 1, p. 230, 2019. PUBLICADA resolução 466 do CNS que trata de pesquisas em seres humanos e atualiza a resolução 196. Conselho Nacional de Saúde (CNS), 2013. Disponível em: https://conselho.saude.gov.br/ultimas_noticias/2013/06_jun_14_publicada_resolucao .html. Acesso em: 16 de julho de 2023. ROSES, D. F. et al. Pathologic predictors of recurrence in stage 1 (TINOMO) breast cancer. American Journal of Clinical Pathology, Oxônia, v. 78, n. 6, p. 817-820, 1982. SIQUEIRA, A. G. Prevenção e rastreamento do câncer de mama. Ana Gabriela Siqueira: Mastologia e Ginecologia, 2020. Disponível em: https://mastologiaesaudedamulher.com/. Acesso em: 16 de julho de 2023. SRIVASTAVA, P. et al. Clinical-pathologic characteristics and response to neoadjuvant chemotherapy in triple-negative low Ki-67 proliferation (TNLP) breast cancers. NPJ Breast Cancer, Berlim, v. 8, n. 1, p. 51, 2022. SUNG, H. et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: ACancer Journal for Clinicians, Kennesaw, v. 71, n. 3, p. 209-249, 2021. TREATMENT: Breast cancer in women. National Health Service, 2022. Disponível em: https://nhs.uk/conditions/breast-cancer/treatment/. Acesso em: 16 de julho de 2023. VALENTIM, M. H.; MONTEIRO, V.; MARQUES, J. C. Primary neuroendocrine breast carcinoma: a case report and literature review. Radiologia Brasileira, São Paulo, v. 47, n. 2, p. 125-127, 2014. WAKS, A. G. e WINER, E. P. Breast Cancer Treatment: A Review. JAMA, Chicago, v. 321, n. 3, p. 288-300, 2019. WATKINS, E. J. Overview of breast cancer. JAAPA, Alexandria, v. 32, n. 10, p.13- 17, 2019. YAZDANI, A. e HAGHIGHAT, S. Determining Prognostic Factors of Disease-Free Survival in Breast Cancer Using Censored Quantile Regression. Breast Cancer: Basic and Clinical Research, Newbury Park, v. 16, p. 11782234221108058, 2022. ZAGAMI, P. e CAREY, L. A. Triple negative breast cancer: Pitfalls and progresso. NPJ Breast Cancer, Berlim, v. 8, n. 1, p. 95, 2022. ZHU, X. et al. The prognostic and predictive potential of Ki-67 in triple-negativebreast cancer. Scientific Reports, Londres, v. 10, n. 1, p. 225, 2020.por
dc.rightsAcesso Abertopor
dc.subjectFatores Prognósticospor
dc.subjectSobrevidapor
dc.subjectCondições Patológicas Anatômicaspor
dc.subjectTerapêuticapor
dc.subjectAvaliação dos Resultados dos Cuidados de Saúdepor
dc.subjectCâncer de Mamapor
dc.subjectPrognostic Factorseng
dc.subjectSurvivaleng
dc.subjectTherapeuticseng
dc.subjectOutcome Assessmenteng
dc.subjectHealth Careeng
dc.subjectBreast Cancereng
dc.subject.cnpqCLINICA MEDICA::GINECOLOGIA E OBSTETRICIApor
dc.subject.cnpqCLINICA MEDICA::CANCEROLOGIApor
dc.subject.cnpqSAUDE COLETIVA::EPIDEMIOLOGIApor
dc.titleSobrevida e fatores prognósticos em pacientes com câncer de mama: um estudo de coortepor
dc.title.alternativeSurvival and prognostic factors in patients with breast cancer: a cohort studyeng
dc.typeMonografiapor
Aparece nas coleções:CCS - Bacharelado em Medicina (Poeta Torquato Neto – TERESINA)

Arquivos associados a este item:
Arquivo Descrição TamanhoFormato 
Monografia completa.pdf4,08 MBAdobe PDFBaixar/Abrir Pré-Visualizar
Mostrar registro simples do item Recomendar este item Visualizar estatísticas


Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.